Shots:
- neurocare has received US FDA clearance for its Apollo Transcranial Magnetic Stimulation (TMS) Therapy devices to treat obsessive-compulsive disorder (OCD)
- The Apollo TMS Therapy system is a non-invasive treatment that uses a magnetic coil on the head to stimulate targeted brain pathways and was previously cleared for major depressive disorder
- The systems support advanced protocols for OCD, providing clinicians with a drug-free alternative that relieves symptoms and improves quality of life for patients with limited options
Ref: neurocare | Image: neurocare| Press Release
Related News:- Rhythm Pharmaceuticals Reports the US FDA’s sNDA Submission of Setmelanotide for Acquired Hypothalamic Obesity
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
